Tilton John
Insider CIK 1704251 · BHVN Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 37,292 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 19,240 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 2,500 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 4,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 7,602 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 10,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 26,916 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 3,084 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 1,250 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 775 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 6,225 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 2,398 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 2,625 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 2,500 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer | 2022-10-03 | 2022-10-03 | 5,068 | $148.50 | $752.6K | 1,614 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer | 2022-10-03 | 2022-10-03 | 1,614 | $148.50 | $239.7K | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2022-01-07 | 2022-01-07 | 3,500 | — | $0 | 3,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-07 | 2022-01-07 | 875 | — | $0 | 2,625 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2022-01-07 | 2022-01-07 | 7,000 | — | $0 | 7,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2022-01-07 | 2022-01-07 | 342 | $128.87 | $44.1K | 4,937 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-07 | 2022-01-07 | 875 | — | $0 | 5,279 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-06 | 2022-01-07 | 1,250 | — | $0 | 2,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2022-01-06 | 2022-01-07 | 551 | $123.86 | $68.2K | 4,404 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-06 | 2022-01-07 | 1,250 | — | $0 | 4,955 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-11-25 | 2021-11-26 | 1,250 | — | $0 | 1,250 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-11-25 | 2021-11-26 | 1,250 | — | $0 | 3,909 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2021-11-25 | 2021-11-26 | 492 | $115.55 | $56.9K | 3,417 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-01-06 | 2021-01-08 | 1,250 | — | $0 | 3,750 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2021-01-06 | 2021-01-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2021-01-06 | 2021-01-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2021-01-06 | 2021-01-08 | 492 | $83.38 | $41.0K | 2,659 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-01-06 | 2021-01-08 | 1,250 | — | $0 | 3,151 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2020-11-25 | 2020-11-27 | 1,250 | — | $0 | 2,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2020-11-25 | 2020-11-27 | 480 | $90.14 | $43.3K | 1,540 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2020-11-25 | 2020-11-27 | 1,250 | — | $0 | 2,020 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2020-06-10 | 2020-06-12 | 52,000 | — | $0 | 37,292 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2020-06-10 | 2020-06-12 | 2,467 | $69.40 | $171.2K | 770 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2020-06-10 | 2020-06-12 | 52,000 | $9.29 | $483.1K | 52,770 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2020-06-10 | 2020-06-12 | 21,364 | $66.70 | $1.42M | 31,406 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2020-06-10 | 2020-06-12 | 5,331 | $68.57 | $365.5K | 3,237 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2020-06-10 | 2020-06-12 | 22,838 | $67.53 | $1.54M | 8,568 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-12-18 | 2019-12-20 | 1,250 | — | $0 | 3,750 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2019-12-18 | 2019-12-20 | 480 | $52.13 | $25.0K | 770 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-12-18 | 2019-12-20 | 1,250 | — | $0 | 1,250 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2019-11-25 | 2019-11-27 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2019-11-25 | 2019-11-27 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-03-12 | 2019-03-14 | 10,000 | — | $0 | 78,792 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-03-12 | 2019-03-14 | 10,000 | $50.11 | $501.1K | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-03-12 | 2019-03-14 | 10,000 | $9.29 | $92.9K | 10,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-01-10 | 2019-01-14 | 10,500 | — | $0 | 10,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-01-10 | 2019-01-14 | 10,500 | $37.67 | $395.5K | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-01-10 | 2019-01-14 | 10,500 | $9.29 | $97.5K | 10,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2017-12-07 | 2017-12-11 | 21,740 | — | $0 | 21,740 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2017-11-01 | 2017-11-02 | 30,000 | — | $0 | 88,792 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2017-11-01 | 2017-11-02 | 21,347 | $29.10 | $621.2K | 8,653 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2017-11-01 | 2017-11-02 | 8,653 | $29.63 | $256.4K | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2017-11-01 | 2017-11-02 | 30,000 | $9.29 | $278.7K | 30,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | C Conversion deriv | 2017-05-09 | 2017-05-11 | 1,614 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | C Conversion | 2017-05-09 | 2017-05-11 | 1,614 | — | $0 | 1,614 | SEC↗ |